➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

Cefoxitin sodium - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for cefoxitin sodium and what is the scope of freedom to operate?

Cefoxitin sodium is the generic ingredient in seven branded drugs marketed by Acs Dobfar, Acs Dobfar Spa, Fresenius Kabi Usa, Hikma Farmaceutica, Hospira Inc, West-ward Pharms Int, B Braun, Mylan Institutional, Merck, and Samson Medcl, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for cefoxitin sodium. Six suppliers are listed for this compound.

Recent Clinical Trials for cefoxitin sodium

Identify potential brand extensions & 505(b)(2) entrants

Haining Health-Coming Biotech Co., Ltd.Phase 2

See all cefoxitin sodium clinical trials

Pharmacology for cefoxitin sodium
Medical Subject Heading (MeSH) Categories for cefoxitin sodium

US Patents and Regulatory Information for cefoxitin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER cefoxitin sodium INJECTABLE;INJECTION 065214-002 Mar 10, 2006 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Acs Dobfar CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065414-002 Jun 12, 2009 AP RX No Yes   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065012-001 Jul 3, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
Merck MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cefoxitin sodium INJECTABLE;INJECTION 050581-002 Sep 20, 1984 DISCN Yes No   Start Trial   Start Trial   Start Trial
Acs Dobfar Spa CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065467-001 Aug 31, 2011 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.